Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Impact of Renal Function Eligibility Criteria on Clinical Trials and Real-World Survival Outcomes Among Patients With Metastatic Renal Cell Carcinoma.
Journal: Clinical genitourinary cancer
Published: January 31, 2025
Contemporary role of avelumab first-line maintenance in advanced urothelial carcinoma with consideration of the JAVELIN Bladder 100 comprehensive clinical subgroup analyses.
Journal: Translational andrology and urology
Published: November 11, 2023
The Genomic Landscape of Urothelial Carcinoma with High and Low ERBB2 Expression.
Journal: Cancers
Published: October 31, 2023
Survival Outcomes in Patients With Muscle-Invasive Bladder Cancer Receiving Neoadjuvant Chemotherapy Stratified by Number of Cycles.
Journal: Clinical genitourinary cancer
Published: September 21, 2023
Bispecific PSMA antibodies and CAR-T in metastatic castration-resistant prostate cancer.
Journal: Therapeutic advances in urology
Published: March 01, 2023
Global Meta-analysis of Urine Microbiome: Colonization of Polycyclic Aromatic Hydrocarbon-degrading Bacteria Among Bladder Cancer Patients.
Journal: European urology oncology
Published: November 11, 2022
Paraneoplastic limbic encephalitis following treatment with single-agent pembrolizumab for advanced gastroesophageal adenocarcinoma.
Journal: BMJ case reports
Published: May 24, 2022
Influence of first-line chemotherapy regimen on survival outcomes of patients with advanced urothelial carcinoma who received second-line immune checkpoint inhibitors.
Journal: Urologic oncology
Published: February 24, 2022
Comparative Effectiveness of Front-Line Ipilimumab and Nivolumab or Axitinib and Pembrolizumab in Metastatic Clear Cell Renal Cell Carcinoma.
Journal: The oncologist
Published: December 23, 2021
Placing Adjuvant Chemotherapy in the Evolving Paradigm of Perioperative Therapy for Bladder Cancer.
Journal: European urology
Published: October 11, 2021
Biomarker Development for Metastatic Renal Cell Carcinoma: Omics, Antigens, T-cells, and Beyond.
Journal: Journal of personalized medicine
Published: October 28, 2020
Last Updated: 09/26/2026